Frequently Asked Questions What is Retatrutide used for
The Wegovy FDA prescribing information lists nausea, vomiting, diarrhea, constipation, and abdominal pain as the most common adverse reactions, with rates highest during titration [3]
Shiu HY, Chong HC, Leung YC, Wong MK, Che CM
The Category-2 prohibition on BPC-157 by name is gone, but final FDA action on its 503A listing is still pending
High-bioavailability glutathione benefits are enhanced glutathione for skin well-being (25% elasticity improvement) and glutathione for liver cleansing (50% enzyme increase)
Lilly has reported strong Phase 3 results, including 28.3% average weight loss over 80 weeks at the highest studied dose in one obesity trial, but the drug still requires regulatory review